Targeted Navigation in Hepatocellular Carcinoma (HCC)
Part of paid clinical trials in Miami, Florida.
- Sponsor
- University of Miami
- Study ID
- NCT06260943
- Status
- Recruiting
Conditions
- Cholangiocarcinoma
- Hepatobiliary Cancer
- Hepatocellular Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Target Navigation Pilot Program — BEHAVIORALParticipants will meet with a navigator, in either English, Spanish or Creole, biweekly, in person or virtually, until the first treatment appointment and every three months after. Each session will last approximately one hour; depending on the needs identified, patients will be connected to appropriate institutional or community-based resources.
Study Details
The investigators are trying to learn more about the personal perceptions and experiences regarding the needs of patients with liver cancer to help improve the care of all patients. The investigators would like to know whether there are needs that patients have or are aware of, especially those needs that the investigators have not been able to address. The investigators aim to develop a program that helps participants and participant's families to navigate the process of being diagnosed with liver cancer and receiving treatment.
Key Dates
- Start date
- Apr 15, 2024
- Status verified
- Jul 2025
- Primary completion
- Oct 31, 2026
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Aim 3: Targeted Navigation Pilot ProgramParticipants in this group will be enrolled in a Targeted Navigation Pilot Program for up to 12 months.
Primary Outcome Measure
Number of Days to First Contact [ Time Frame: Up to 12 months ]
Central Contacts
- Gloria Figueroa(305) 243-0779
- Patricia Jones, MD(305) 243-0779
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Miami | Miami | Florida | 33136 | Patricia Jones, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Miami, FL
By condition
By specialty
By research site
Related Studies
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid TumoursPHASE1/PHASE2 · Recruiting · Bold Therapeutics, Inc. · Santa Monica, California
- Multi-analyte Blood Test Clinical TrialRecruiting · Helio Genomics · Mission Hills, California
- An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic CholangiocarcinomaPHASE2 · Recruiting · Virogin Biotech Canada Ltd · Phoenix, Arizona